Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-22-000027 General Corporate
Debt relative to revenue 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
213.10% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.47% · OPTIONAL · VALID
Operating cash generation 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.17% · OPTIONAL · VALID
Revenue growth 30th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
1.60% · CORE · VALID
Inventory pressure 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
79.78% · OPTIONAL · VALID
Gross margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
36.83% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
17.06% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.76% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.71% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 198.42%
Current 213.10%
Delta 14.69% Capex Intensity Increased
Previous 1.41%
Current 1.47%
Delta 0.06% Cash Generation Increased
Previous 5.09%
Current 15.17%
Delta 10.08% Growth Increased
Previous -1.95%
Current 1.60%
Delta 3.55% Inventory Pressure Increased
Previous 79.23%
Current 79.78%
Delta 0.55% Margin Decreased
Previous 37.50%
Current 36.83%
Delta -0.67% Profitability Increased
Previous 16.10%
Current 17.06%
Delta 0.96% R And D Intensity Decreased
Previous 3.92%
Current 2.76%
Delta -1.16% Sbc Intensity Increased
Previous 0.62%
Current 0.71%
Delta 0.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.